We are grateful to the mothers that participated in the study, the clinical teams at the Manhiça District Hospital, the Magude Health Center, and the Ilha Josina Health center, and the personnel at CISM and ISGlobal . We are also grateful to Dr. Deepak Gaur who offered very generously recombinant proteins produced in his lab.
Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, London, UKUniversité de Paris, Biologie Intégrée du Globule Rouge, UMR_S1134, Inserm, 75015, Paris, FranceDepartment of Parasites & Insect Vectors, Malaria Parasite Biology and Vaccines, Institut Pasteur, Paris, FranceMalaria Group, International Centre for Genetic Engineering and Biotechnology , New Delhi, IndiaEusébio MaceteDepartment of Physiologic Sciences, Faculty of...
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
Health Health Latest News, Health Health Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Anti-Viral Responses of Tissue-Resident CD49a+ Lung NK Cells Are Dysregulated in COPD | American Journal of Respiratory and Critical Care Medicine | Articles in Press
Source: medical_xpress - 🏆 101. / 51 Read more »
Combining tau-PET and fMRI meta-analyses for patient-centered prediction of cognitive decline in Alzheimer’s disease - Alzheimer's Research & TherapyBackground Tau-PET is a prognostic marker for cognitive decline in Alzheimer’s disease, and the heterogeneity of tau-PET patterns matches cognitive symptom heterogeneity. Thus, tau-PET may allow precision-medicine prediction of individual tau-related cognitive trajectories, which can be important for determining patient-specific cognitive endpoints in clinical trials. Here, we aimed to examine whether tau-PET in cognitive-domain-specific brain regions, identified via fMRI meta-analyses, allows the prediction of domain-specific cognitive decline. Further, we aimed to determine whether tau-PET-informed personalized cognitive composites capture patient-specific cognitive trajectories more sensitively than conventional cognitive measures. Methods We included Alzheimer’s Disease Neuroimaging Initiative (ADNI) participants classified as controls (i.e., amyloid-negative, cognitively normal, n=121) or Alzheimer’s disease-spectrum (i.e., amyloid-positive, cognitively normal to dementia, n=140), plus 111 AVID-1451-A05 participants for independent validation (controls/Alzheimer’s disease-spectrum=46/65). All participants underwent baseline 18F-flortaucipir tau-PET, amyloid-PET, and longitudinal cognitive testing to assess annual cognitive changes (i.e., episodic memory, language, executive functioning, visuospatial). Cognitive changes were calculated using linear mixed models. Independent meta-analytical task-fMRI activation maps for each included cognitive domain were obtained from the Neurosynth database and applied to tau-PET to determine tau-PET signal in cognitive-domain-specific brain regions. In bootstrapped linear regression, we assessed the strength of the relationship (i.e., partial R2) between cognitive-domain-specific tau-PET vs. global or temporal-lobe tau-PET and cognitive changes. Further, we used tau-PET-based prediction of domain-specific decline to compose personalized cognitive composites that were tailored to capture patient-specific cognitive decline. Resu
Source: BioMedCentral - 🏆 22. / 71 Read more »
Unusual type of antibody shows ultrapotent activity against ZikaAn unusual type of antibody that even at miniscule levels neutralizes the Zika virus and renders the virus infection undetectable in preclinical models has been identified by a team led by Weill Cornell Medicine, New York-Presbyterian and National Institutes of Health (NIH) investigators.
Source: medical_xpress - 🏆 101. / 51 Read more »